Sinopharm Group Co. Ltd. (SHTDY)

Sinopharm Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,371	8,557	8,169	7,940	6,787	7,591
Market Cap Growth	-9.50%	4.75%	2.88%	16.99%	-10.59%	-29.97%
Enterprise Value	18,622	23,029	20,352	19,036	19,278	16,823
Last Close Price	11.74	13.57	12.58	11.80	9.76	10.51
PE Ratio	7.55	8.86	6.40	6.42	5.56	6.90
PS Ratio	0.09	0.11	0.10	0.10	0.08	0.11
PB Ratio	0.41	0.49	0.48	0.50	0.43	0.55
P/TBV Ratio	0.76	0.89	0.90	0.95	0.84	1.08
P/FCF Ratio	2.28	6.20	3.81	2.91	5.96	5.35
P/OCF Ratio	2.16	5.41	3.37	2.61	4.63	4.44
EV/Sales Ratio	0.23	0.29	0.24	0.24	0.24	0.24
EV/EBITDA Ratio	5.83	8.42	5.91	5.30	5.35	5.26
EV/EBIT Ratio	7.24	9.43	6.47	5.77	5.84	5.75
EV/FCF Ratio	5.77	16.68	9.49	6.97	16.93	11.86
Debt / Equity Ratio	0.61	0.60	0.61	0.63	0.69	0.76
Debt / EBITDA Ratio	3.56	3.42	2.78	2.60	2.76	3.04
Debt / FCF Ratio	3.37	7.58	4.85	3.69	9.45	7.40
Asset Turnover	-	1.51	1.60	1.58	1.61	1.57
Inventory Turnover	-	8.83	9.06	8.98	9.68	9.28
Quick Ratio	1.07	1.06	1.06	0.99	1.01	0.99
Current Ratio	1.34	1.39	1.40	1.36	1.33	1.31
Return on Equity (ROE)	8.24%	8.44%	13.03%	13.68%	13.78%	14.50%
Return on Assets (ROA)	-	2.87%	3.73%	4.06%	4.06%	4.11%
Return on Capital (ROIC)	5.47%	5.61%	7.46%	8.18%	8.03%	8.22%
Return on Capital Employed (ROCE)	12.50%	12.50%	15.70%	17.50%	18.10%	17.80%
Earnings Yield	13.25%	11.29%	15.63%	15.57%	17.99%	14.50%
FCF Yield	43.81%	16.13%	26.26%	34.39%	16.78%	18.68%
Dividend Yield	4.25%	0.69%	0.98%	1.01%	1.21%	1.00%
Payout Ratio	29.23%	38.51%	28.26%	27.45%	27.75%	25.95%
Buyback Yield / Dilution	-0.35%	-	-0.12%	0.12%	-0.30%	-4.70%
Total Shareholder Return	3.90%	0.69%	0.86%	1.13%	0.91%	-3.69%

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.